Registration of Icaridine

(sec-butyl 2-(2-hydroxyethyl)piperidine-1- carboxylate) 

Mandatory approval for products containing lcaridin as the sole active ingredient or in a combination of active ingredients!

 

Alexander Brux

phone +49 (0) 2204 83077-23
mobile +49 (0) 151 168 87 532
alexander.brux(at)biogenius.de

Dr. Catherine Linn

phone +49 (0) 2204 83077-17
mobile +49 (0) 160 5346785
catherine.linn(at)biogenius.de

Registration of Icaridine

Since December 2019 Icaridin is part of the BPR. In combination with other substances or single, there is now an authorization requirement for Icaridin. Please consider the time for creating a dossier that takes about 10 to 12 months. Hence, the authorization have to be turned in until 01.02.2022.

We as BioGenius are your competent test institute and looking forward to assisting you with e. g. required adjustments in formulations (screenings in advance). Before the authorization we offer technical consulting to design suitable registration data sets e. g. time scheduling, calculation and create possible solutions for your unique products. Our combined services include studies in analytics, stability, physico-chemical data and efficacy.

Please don’t hesitate to contact us for further information, to get a calculation without any commitment and of course to ask your questions.

Your Competent Test Institute.